Search

You searched for "imagers"

1754 results found

Systemic sarcoidosis presenting with acute myopia and angle closure

1 June 2016 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Strabismus, EYE - Refractive, EYE - Vitreo-Retinal
Case report A 40-year-old Asian man presented to the Emergency Department with a one day history of sudden onset visual disturbance in his right eye. He complained of image distortion and noted that objects now appeared smaller. He also described...

An uncommon late postoperative complication of combined cataract surgery and intravitreal triamcinolone injection

1 December 2014 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Case report A 64-year-old female with diabetic maculopathy (DMO) underwent phacoemulsification with intraocular lens (IOL) implantation in her right eye combined with intravitreal triamcinolone (IVTA). Diabetes control was poor with HbA1c (IFCC) of 119mmol/mol and blood sugar level of 27mmol/L....

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

29 March 2023 | glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

New research shows the unhealthy state of access to medicine and medical devices for blind patients

30 April 2025 | RNIB, The Safety Gap, risk assessment, diabetes, patient experience, public awareness
Blind and partially sighted people could become ill from medicines and medical devices, because they are not being listened to when it comes to designing, prescribing and administering treatments. The Safety Gap’ report commissioned by the Patient Safety Commissioner, Prof...

Hydroxychloroquine toxicity

1 August 2017 | EYE - Vitreo-Retinal, EYE - General
Being the subject of litigation is stressful and upsetting. Having to look back over your previous decisions and justify the care you delivered in good faith can be difficult. Sadly, we all live with the Sword of Damocles above us...

Eyes on Rwanda: Lessons from an international ophthalmology experience

2 October 2025 | | EYE - Cataract, EYE - Glaucoma
On the 26 February 2025, I travelled to Rwanda on the invitation of a former Belfast trainee, Michael Mikhail. Michael is now one of only two vitreoretinal (VR) surgeons in Rwanda, a country with a population of 14 million. Born...

ZEISS Supports World Sight Day 2024

7 October 2024 | cataract, industry news, ZEISS, WSD24, World Sight Day, IOFF
In honor of World Sight Day, ZEISS Medical Technology and ZEISS Vision Care celebrate some of the work being done around the world through healthcare organizations, providing donations that support and education that inspires patients and doctors to champion better...

Enhancing glaucoma awareness and management in Nigeria – from grass roots to national policy development

5 June 2023 | | EYE - General
This is the second in a series (see Part 1 here) of three articles about strengthening eye health services in Nigeria through collaboration with the LINKS and Networks run at the International Centre for Eye Health, LSHTM. This article highlights...

Building capacity in eye health: A story of partnerships and collaborations

4 December 2024 | | EYE - Vitreo-Retinal
In the evolving landscape of global eye health, partnerships and collaborations have been instrumental in driving capacity building and professional development. The impact of strategic alliances like VISION 2020 LINKS and the Diabetic Retinopathy Network (DR-NET) cannot be overstated, as...

Primary eye health care in low- and middle-income countries

2 February 2024 | | EYE - Cataract, EYE - Refractive, EYE - Paediatrics, EYE - Strabismus
The need for eyecare services in low- and middle-income countries Recent global estimates (2020) suggest that there is more than a three-fold difference in the prevalence of all categories of visual loss (presenting visual acuity <6/12 in the better eye)...

Designing ophthalmology services Part 3: How do we address the queues post‑COVID-19?

5 August 2020 | | EYE - Cataract, EYE - Refractive, EYE - Vitreo-Retinal, EYE - General
Part 1 of this series available herePart 2 of this series available here There is going to be enormous demand on ophthalmology services as they start to welcome patients back. The authors explain how modelling can help make the most...

My Top Five: Innovations in the diagnosis of ocular tumours

4 February 2025 | | EYE - Oncology, EYE - Orbit, EYE - Pathology
Ocular tumours can vary widely in origin, from benign growths to metastases from distant disseminated malignancies. Although rare, ocular tumours pose a significant health and economic burden globally, with ocular cancers accounting for 0.2% of all diagnosed malignancies in the...